LONDON (Reuters) - AstraZeneca Plc is seeking European approval to sell its drug Seroquel XR as a treatment for anxiety, the Anglo-Swedish group said on Tuesday. If approved, Seroquel XR would be the ...
An investigational drug did not significantly improve outcomes versus quetiapine extended release (Seroquel XR) as an adjunctive treatment in adults with major depressive disorder (MDD) and insomnia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback